Ole A. Holtermann

636 total citations
33 papers, 441 citations indexed

About

Ole A. Holtermann is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Ole A. Holtermann has authored 33 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Ole A. Holtermann's work include Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Virus-based gene therapy research (5 papers). Ole A. Holtermann is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Virus-based gene therapy research (5 papers). Ole A. Holtermann collaborates with scholars based in United States, Denmark and Venezuela. Ole A. Holtermann's co-authors include Edmund Klein, Halina Milgrom, George P. Casale, Jeannine A. Majde, Gordon H. Burgess, Robert A. Schwartz, W. Daniel Hillis, Margaret A. J. Moffat, Edward A. Havell and Isaac Djerassi and has published in prestigious journals such as Nature, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

Ole A. Holtermann

33 papers receiving 368 citations

Peers

Ole A. Holtermann
Anupama Salvekar United States
Carol A. Smith United States
Nancy J. Dooley United States
K Saizawa United States
Y M Naidu United States
Cory A. Waters United States
Margaret K. Deringer United States
N.W. Robinson United Kingdom
Xiuqin Guan United States
D. A. Hardy United Kingdom
Anupama Salvekar United States
Ole A. Holtermann
Citations per year, relative to Ole A. Holtermann Ole A. Holtermann (= 1×) peers Anupama Salvekar

Countries citing papers authored by Ole A. Holtermann

Since Specialization
Citations

This map shows the geographic impact of Ole A. Holtermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole A. Holtermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole A. Holtermann more than expected).

Fields of papers citing papers by Ole A. Holtermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole A. Holtermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole A. Holtermann. The network helps show where Ole A. Holtermann may publish in the future.

Co-authorship network of co-authors of Ole A. Holtermann

This figure shows the co-authorship network connecting the top 25 collaborators of Ole A. Holtermann. A scholar is included among the top collaborators of Ole A. Holtermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole A. Holtermann. Ole A. Holtermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bealmear, Patricia M., E. A. Mirand, & Ole A. Holtermann. (1983). Modification of graft-vs-host disease following bone marrow transplantation in germfree mice.. PubMed. 132C. 409–21. 5 indexed citations
2.
Holtermann, Ole A., et al.. (1983). Mycosis fungoides: An overview. Journal of Surgical Oncology. 22(4). 221–227. 5 indexed citations
3.
Klein, Edmund, et al.. (1980). Treatment of kaposi's sarcoma with vinblastine. Cancer. 45(3). 427–431. 62 indexed citations
4.
Schwartz, Robert A., Gordon H. Burgess, Ole A. Holtermann, et al.. (1980). Mycosis fungoides associated with florid sarcoid reactions. Journal of Surgical Oncology. 14(4). 347–357. 24 indexed citations
5.
Klein, Edmund, James Solomon, Untae Kim, et al.. (1979). Explorations of antimitotic agents in the treatment of a congenital disease, Ichthyosis Linearis Circumflexa. Journal of Surgical Oncology. 11(2). 85–88. 9 indexed citations
6.
Klostergaard, Jim, et al.. (1978). Activation of Neutrophilic Granulocytes by Products of Human Lymphocytes. International Archives of Allergy and Immunology. 57(6). 542–548. 2 indexed citations
7.
Papermaster, Ben W., Ole A. Holtermann, Edmund Klein, et al.. (1976). Preliminary observations on tumor regressions induced by local administration of a lymphoid cell culture supernatant fraction in patients with cutaneous metastatic lesions. Clinical Immunology and Immunopathology. 5(1). 31–47. 22 indexed citations
8.
Klein, Edmund, et al.. (1976). Immunotherapy for Accessible Tumors Utilizing Delayed Hypersensitivity Reactions and Separated Components of the Immune System. Medical Clinics of North America. 60(3). 389–418. 38 indexed citations
9.
Papermaster, Ben W., et al.. (1976). Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regression. Clinical Immunology and Immunopathology. 5(1). 48–59. 21 indexed citations
10.
Holtermann, Ole A., et al.. (1975). Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens or lymphokines.. PubMed. 6(2). 157–68. 11 indexed citations
11.
Klein, Edmund, Gordon H. Burgess, Alexander Bloch, Halina Milgrom, & Ole A. Holtermann. (1975). THE EFFECTS OF NUCLEOSIDE ANALOGS ON CUTANEOUS NEOPLASMS*. Annals of the New York Academy of Sciences. 255(1). 216–224. 11 indexed citations
12.
Holtermann, Ole A., et al.. (1975). Cytocidal and cytostatic effects of activated peritoneal leukocytes. Nature. 257(5523). 228–229. 11 indexed citations
13.
Holtermann, Ole A., Edmund Klein, & George P. Casale. (1973). Selective cytotoxicity of peritoneal leucocytes for neoplastic cells. Cellular Immunology. 9(3). 339–352. 55 indexed citations
14.
Holtermann, Ole A. & Edward A. Havell. (1970). Reduced Interferon Response in Mice Congenitally Infected with Lymphocytic Choriomeningitis Virus. Journal of General Virology. 9(1). 101–103. 14 indexed citations
15.
Holtermann, Ole A. & Albert A. Nordin. (1969). The Effect of Cytosine Arabinoside upon the Primary Immune Response in Vitro. Experimental Biology and Medicine. 132(3). 1003–1005. 3 indexed citations
16.
Holtermann, Ole A. & Jeannine A. Majde. (1969). Rejection of Skin Grafts from Mice chronically infected with Lymphocytic Choriomeningitis Virus by non-infected Syngeneic Recipients. Nature. 223(5206). 624–624. 14 indexed citations
17.
Holtermann, Ole A.. (1969). Amino Acid Requirement for the Propagation of Vaccinia Virus in Earle's L Cells. Journal of General Virology. 4(4). 585–591. 9 indexed citations
18.
Holtermann, Ole A. & Albert A. Nordin. (1968). Primary Induction of Plaque Forming Antibody Producing Cells in Spleen Organ Culture. Experimental Biology and Medicine. 127(3). 675–678. 4 indexed citations
19.
Holtermann, Ole A., W. Daniel Hillis, & Margaret A. J. Moffat. (1960). The Development of Soluble (S) And Viral (V) Antigens of Influenza A Virus In Tissue Culture As Studied By The Fluorescent Antibody Technique. Acta Pathologica Microbiologica Scandinavica. 50(4). 398–408. 20 indexed citations
20.
Holtermann, Ole A., S. E. Mergenhagen, & H. R. Morgan. (1959). Factors Related to Psittacosis Virus (Strain 6BC) Growth. V. Folic Acid-like Factor in Infected Cells.. Experimental Biology and Medicine. 100(2). 370–372. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026